SHELTON, Conn. -- PerkinElmer, Inc. (NYSE: PKI), a leading provider of drug discovery, life science research and analytical solutions, today announced that its Clarus® gas chromatograph (GC) and TurboMatrixTM headspace and thermal desorption systems are now available with a Chinese-language touch-screen interface. For labs in China and other regions staffed by native speakers of Chinese, the new interface combines Chinese-language menus and intuitive icon-driven sample handling operations, providing ease-of-use and enhancing productivity.
Chinese is the eighth native-language interface to be added to the Clarus and TurboMatrix product lines. Other supported languages include English, German, French, Spanish, Italian, Russian and Japanese. The design of the PerkinElmer instrument interface and supporting software and firmware are uniquely suited to rapid development of additional local language interfaces.
"PerkinElmer is committed to further simplifying the operation of our instruments and the addition of a Chinese-language interface is important for our customers," said Jonathan Rennert, vice president and general manager, Environmental and Chemical business at PerkinElmer, Inc. "Extending local-language support across both sample handling and instrument operation will allow users to concentrate on what matters most-results."
Dr. Lin Li, Asian business development manager, Environmental and Chemical business at PerkinElmer, Inc., added, "China is growing quickly and labs are expanding to meet the needs of industry and government. Our addition of Chinese-language support will speed adoption of our integrated GC solutions throughout China and other countries that employ Chinese scientists and technicians."
PerkinElmer Clarus gas chromatographs and other analytical instruments are widely used in the chemical, food and beverage, materials and petrochemical industries for new product development, quality control and environmental monitoring. The recently introduced TurboMatrix headspace sampling system with optional trap offers up to 100 times lower detection limits for gas chromatography-a significantly higher level of performance compared with conventional sampling systems-while ensuring high accuracy, simplified sample preparation and enhanced throughput.
Clarus and TurboMatrix systems with the new Chinese-language interface are available immediately. For more information about PerkinElmer Clarus gas chromatography systems and TurboMatrix headspace sampling systems, including literature describing the available languages, visit www.perkinelmer.com/gc.
Continuing its fifty-year tradition of GC innovation, PerkinElmer is the only supplier that manufactures and sells a complete single-vendor solution - from sample handling to data handling.
Factors Affecting Future Performance
This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements contained in this press release that relate to prospective events or developments are deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions are intended to identify forward-looking statements. There are a number of important risk factors that could cause actual results or events to differ materially from those indicated by these forward-looking statements, including risks related to cyclical downturns affecting several of the industries into which we sell our products, our failure to introduce new products in a timely manner, the impact of our debt on our cash flow and investment opportunities, our ability to comply with financial covenants contained in our credit agreements and debt instruments, risks related to our international operations, our ability to adjust our operations to address unexpected changes, our ability to execute acquisitions and license technologies and successfully integrate acquired businesses and licensed technologies into our existing business, the loss of any of our licenses that may require us to stop selling products or lose competitive advantage, competition, regulatory changes, our failure to obtain and enforce intellectual property protection, our defense of third party claims of patent infringement and our ability to realize the full value of our intangible assets, as well as other factors which we describe under the caption "Forward-Looking Information and Factors Affecting Future Performance" in our most recently filed annual report on Form 10-K and in our most recently filed quarterly report on Form 10-Q. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.
PerkinElmer, Inc. is a global technology leader focused in the following businesses - Life and Analytical Sciences, Optoelectronics and Fluid Sciences. Combining operational excellence and technology expertise with an intimate understanding of our customers' needs, PerkinElmer provides products and services in health sciences and other advanced technology markets that require innovation, precision and reliability. The Company serves customers in more than 125 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.